← All trials
NCT00786188
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2008
- Primary completion
- Jun 1, 2009
- Completion date
- Jun 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 102
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Noven TherapeuticsLead sponsor
- North Spokane Women's Clinic, Spokane, WA 99207Overall official - principal investigator
- Women's Clinical Research Center, SeattleOverall official - principal investigator
- Department of Veteran AffairsOverall official - principal investigator
- Altus ResearchOverall official - principal investigator
- Hawthorne Medical Research, IncOverall official - principal investigator
- Philadelphia Clinical Research, LLCOverall official - principal investigator
- National Clinical Research - Richmond, Inc.Overall official - principal investigator
- Anchor Research CenterOverall official - principal investigator
- Chattanooga Medical Research, LLCOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.